0 Commentaires
0 Parts
263 Vue
0 Aperçu
Rechercher
Découvrez de nouvelles personnes, créer de nouvelles connexions et faire de nouveaux amis
-
Fil d’actualités
- EXPLORER
-
Pages
-
Groupes
-
Evènements
-
Blogs
-
Offres
-
Emplois
-
Forums
-
Connectez-vous pour aimer, partager et commenter!
-
Biosimilars Market Evolution: Innovation, Access, and GrowthThe pharmaceutical landscape is undergoing one of its most significant transformations since the dawn of small-molecule generics. At the heart of this shift is a profound transition toward biologic therapies and, by extension, the highly anticipated waves of biosimilars designed to make these life-saving drugs accessible to a broader demographic. For healthcare administrators, pharmaceutical...0 Commentaires 0 Parts 45 Vue 0 Aperçu
-
Biosimilars Market Expands with Patent Expirations of BiologicsIn the high-stakes world of modern medicine, we are currently witnessing a structural realignment of the pharmaceutical industry. If the early 2010s were defined by the "patent cliff" of small-molecule blockbusters like Lipitor, 2026 marks the dawn of a far more complex era. This is the year of the biological "super-cliff," where the Biosimilars Market 2026 is poised to bridge the gap...0 Commentaires 0 Parts 238 Vue 0 Aperçu
-
Hematology Biosimilars Market Assessment Report Covering Trends, Forecast & Opportunities"Hematology Biosimilars Market Summary: According to the latest report published by Data Bridge Market Research, the Hematology Biosimilars Market The global hematology biosimilars market size was valued at USD 257.4 billion in 2025 and is expected to reach USD 535.911 billion by 2033, at a CAGR of 9.60% during the forecast period The Hematology...0 Commentaires 0 Parts 181 Vue 0 Aperçu
-
Adalimumab Biosimilar Market Size, Share, Growth Trends, Industry Analysis, and Forecast 2026–2032 Driven by Rising Demand for Cost-Effective Biologic Therapies and Expanding Biosimilar AdoptionAccording to the latest report published by Data Bridge Market Research, the Adalimumab Biosimilar Market Data Bridge Market Research analyses that the adalimumab biosimilar market which is USD 598.30 million in 2022, is expected to reach USD 3431.48 million by 2030, at a CAGR of 24.4% during the forecast period 2023 to 2030. This Adalimumab Biosimilar Marketdocument provides with...0 Commentaires 0 Parts 47 Vue 0 Aperçu
-
Biologic Medications for Psoriasis Market Expanding at 7.8% CAGR from 2026–2034 with Strong Industry AdoptionAccording to a new report from Intel Market Research, the global biologic medications for psoriasis market was valued at USD 14.5 billion in 2025 and is projected to reach USD 28.7 billion by 2034, growing at a CAGR of 7.8% during the forecast period (2026–2034). This growth is fueled by increasing psoriasis prevalence, superior efficacy of biologics over conventional treatments, and...0 Commentaires 0 Parts 613 Vue 0 Aperçu
-
Pharmaceuticals Market Trends and Forecast to 2031: Strategic Insights, Innovation Drivers, and Growth OpportunitiesThe global pharmaceuticals market is progressing at a strong and steady pace, supported by increasing demand for advanced therapeutics, expanding healthcare systems, and continuous innovation in drug development. The market is projected to grow from US$ 1,757.78 billion in 2024 to US$ 2,840.30 billion by 2031, registering a CAGR of 7.1% during 2025–2031. This growth reflects the...0 Commentaires 0 Parts 847 Vue 0 Aperçu
English
Arabic
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek